NIH 3T3 cells expressing FGFR3-TACC3 fusion protein are selectively inhibited by FGFR inhibitors such as PD173074 compared to cells expressing FGFR3 WT that are unaffected (Supplemental Fig. S5A) in agreement with observations using cancer cell lines (Lamont et al., 2011). This evidence concerns the gene FGFR3 and cancer.